PXR activation via a genetic approach (constitutive activation) or pharmacologic activation via rifampicin protected colon cancer cells from chemically induced apoptosis. PXR activation in transgenic mice inhibited bile acid-induced colonic epithelial apoptosis and sensitized mice to dimethylhydrazine-induced colon carcinogenesis. Here, NR1I2 is linked to colonic neoplasm.